TERRESTRIAL BIO Trademark
Trademark Overview
On Friday, January 23, 2026, a trademark application was filed for TERRESTRIAL BIO with the United States Patent and Trademark Office. The USPTO has given the TERRESTRIAL BIO trademark a serial number of 99611841. The federal status of this trademark filing is APPROVED FOR PUBLICATION as of Saturday, May 23, 2026. This trademark is owned by Vaxess Technologies, Inc.. The TERRESTRIAL BIO trademark is filed in the Pharmaceutical Products category with the following description:
Drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of a wide range of pharmaceuticals, and applicators therefor; drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of pharmaceuticals, namely, vaccines, anti-viral therapies, immunotherapies, hormones for medical purposes, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, and fertility diseases, and applicators therefor; patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of vitamins and nutritional supplements, and applicators therefor
General Information
| Serial Number | 99611841 |
| Word Mark | TERRESTRIAL BIO |
| Filing Date | Friday, January 23, 2026 |
| Status | 680 - APPROVED FOR PUBLICATION |
| Status Date | Saturday, May 23, 2026 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| NOT AVAILABLE | "BIO" |
| Goods and Services | Drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of a wide range of pharmaceuticals, and applicators therefor; drug delivery agents in the form of patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of pharmaceuticals, namely, vaccines, anti-viral therapies, immunotherapies, hormones for medical purposes, treatments for obesity, cardio-metabolic diseases, pain, cough, colds, allergies, autoimmune diseases, dermatological diseases and disorders, and fertility diseases, and applicators therefor; patches, polymers, and resorbable microneedles that provide epidermal and intra-dermal delivery of vitamins and nutritional supplements, and applicators therefor |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, January 23, 2026 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | Vaxess Technologies, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Woburn, MA 01801
US |
Trademark Events
| Event Date | Event Description |
| Friday, January 23, 2026 | NEW APPLICATION ENTERED |
| Friday, January 23, 2026 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Friday, January 23, 2026 | APPLICATION FILING RECEIPT MAILED |
| Thursday, May 21, 2026 | ASSIGNED TO EXAMINER |
| Saturday, May 23, 2026 | EXAMINERS AMENDMENT -WRITTEN |
| Saturday, May 23, 2026 | EXAMINERS AMENDMENT E-MAILED |
| Saturday, May 23, 2026 | EXAMINER'S AMENDMENT ENTERED |
| Saturday, May 23, 2026 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Saturday, May 23, 2026 | APPROVED FOR PUB - PRINCIPAL REGISTER |
